Valneva SE provided revenue guidance for the fiscal year 2022. For the period, the company expects the revenue to be in the range of 430 million to 590 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.436 EUR | +2.44% |
|
+7.31% | -27.20% |
Jul. 01 | Valneva's Secures Marketing Authorization in Europe for Chikungunya Vaccine | MT |
Jul. 01 | New semester, new state of mind | ![]() |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.20% | 521M | |
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |
- Stock Market
- Equities
- VLA Stock
- News Valneva
- Valneva SE Provides Revenue Guidance for the Fiscal Year 2022